Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR : MYCN amplification as a marker for genomic instability in neuroblastomas
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-06-01
著者
-
Nistal Manuel
Department Of Pathology La Paz Hospital
-
MUNOZ Jorge
Molecular Neuro-Oncology Laboratory, University of Navarra
-
VENDRELL Elisenda
Cancer Research Institute (IRO), L'Hospitalet de Llobregat
-
AIZA Gemma
Cancer Research Institute (IRO), L'Hospitalet de Llobregat
-
PESTANA Angel
Institute of Biomedical Research Alberto Sols, CSIC
-
PEINADO Miguel
Cancer Research Institute (IRO), L'Hospitalet de Llobregat
-
CASTRESANA Javier
Molecular Neuro-Oncology Laboratory, University of Navarra
-
Nistal Manuel
Department Of Pathology Hospital Universitario "la Paz
-
Aiza Gemma
Cancer Research Institute (iro) L'hospitalet De Llobregat
-
Munoz Jorge
Molecular Neuro-oncology Laboratory University Of Navarra
-
Pestana Angel
Institute Of Biomedical Research "a. Sols" Csic-uam
-
Pestana Angel
Institute Of Biomedical Research Alberto Sols Csic
-
Peinado Miguel
Cancer Research Institute (iro) L'hospitalet De Llobregat
-
Vendrell Elisenda
Cancer Research Institute (iro) L'hospitalet De Llobregat
-
Castresana Javier
Molecular Neuro-oncology Laboratory University Of Navarra
関連論文
- Teratomas of the neck and mediastinum in children
- Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR : MYCN amplification as a marker for genomic instability in neuroblastomas
- New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients : genetic counseling implications